Core Points - The company reported a revenue of 9.523 billion yuan for 2024, representing a year-on-year growth of 37.65%, and a net profit of 1.465 billion yuan, which is an increase of 282.63% compared to the previous year [2][7] - The company achieved a capacity utilization rate of 100% and focused on optimizing market layout to gain more market share, leading to significant performance growth [2][3] - The company is facing an 80% tariff on medical-grade nitrile gloves, a 55% tariff on industrial-grade nitrile gloves, and a 30% tariff on PVC gloves in the U.S. market, which accounts for approximately 30%-35% of its overseas revenue [4][7] Performance Disclosure - For 2024, the company reported a revenue of 9.523 billion yuan, a 37.65% increase year-on-year, and a net profit of 1.465 billion yuan, reflecting a 282.63% growth compared to the previous year [2][7] - The company maintained a capacity utilization rate of 100%, indicating strong operational efficiency [2] Institutional Research - During the performance briefing on May 19, the company attributed its 2024 growth to improved supply-demand dynamics in the disposable glove industry and increased sales prices compared to 2023 [3] - The company is leveraging its production, capital, and sales channel advantages to capture a larger market share [3] Company Announcements - The company has repurchased 2,523,900 shares, accounting for 0.3906% of its total share capital, with a total transaction amount of approximately 53.52 million yuan [5] - The company plans to distribute a total cash dividend of approximately 269.61 million yuan for 2024, which represents 18.40% of the net profit attributable to shareholders [6] - The company is adjusting its 2022 restricted stock incentive plan's performance assessment indicators due to geopolitical complexities and trade friction risks, which will be submitted for shareholder approval [8]

业，精益求精，加大多元化市场布局力度与整合上下游供应链等工 作，2024 年度公司充分发挥了现有生产、资本、销售渠道等方面的 优势，争取占有更多的市场份额。报告期内，公司产能利用率达 100%。因此 2024 年度公司业绩收获了良好增长，经营情况保持行业 领先水平。感谢您的关注！ 2、目前美国对中国一次性手套关税为多少？ 回复：尊敬的投资者您好，目前美国对中国一次性医疗级丁腈 手套关税为 80%，一次性工业级丁腈手套关税为 55%，一次性 PVC 手套关税为 30%。 证券代码：300677 证券简称：英科医疗 英科医疗科技股份有限公司 投资者关系活动记录表 编号：2025-002 | | | | □特定对象调研□分析师会议 | | | --- | --- | --- | --- | --- | | | □媒体采访■业绩说明会 | | | | | 投资者关系活动类别 | □新闻发布会□路演活动 | | | | | | □现场参观 □一对一沟通 | | | | | | □其他 | | | | | 参与单位名称 | 社会公众、投资者等 | | | | | 地点 | 中 国 证 券 报 · 中 证 网 " 路 演 ...

证券代码：300677 证券简称：英科医疗 英科医疗科技股份有限公司 2、采取什么方式进行市值管理？ 回复：尊敬的投资者您好，公司一直积极采取措施不断提升市场 竞争力，一方面，公司不断拓展国内外市场，优化业务布局，提升市 场份额；另一方面，公司持续进行改善创新，推动技术创新和产品升 级，以适应市场变化和客户需求。公司也持续关注股东的合理诉求， 进一步强化投资者回报机制，努力实现公司与股东的共同成长。此 外，公司也通过股份回购等方式，增强市场信心，维护公司价值及股 东权益。未来公司将继续专注主营业务的发展，不断提升自身的核心 竞争力和盈利能力。同时，积极关注市场动态和行业趋势，着力实现 公司的可持续发展。感谢您对公司的关注与支持！ | | 金分红，纳入现金分红的相关比例计算"，因此 年度回购注销金 2024 | | --- | --- | | | 额 173,626,683.00 元视同 2024 年度现金分红金额。公司 2024 年度利 | | | 润分配预案中拟分配的现金红利总额约为人民币 6,391.65 万元（含 | | | 税）。综上，如 2024 年度利润分配预案经股东大会审议通过，2024 年 | ...